ArticleMolecular therapy : the journal of the American Society of Gene Therapy2015

S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.

Julia Ritterhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.